Mckesson (MCK) Capital Expenditures Growth (3y) (2012 - 2026)
Mckesson (MCK) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 12.82% |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 29.42% |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 6.75% |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | -6.75% |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | - |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | -28.22% |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | - |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | -62.68% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.82% |
| Mar 31, 2026 | 40.32% |
| Dec 31, 2025 | -30.55% |
| Sep 30, 2025 | 157.13% |
| Jun 30, 2025 | 3.18% |
| Mar 31, 2025 | 153.03% |
| Dec 31, 2024 | -41.83% |
| Sep 30, 2024 | 88.56% |
| Jun 30, 2024 | -2.59% |
| Mar 31, 2024 | -19.97% |
| Dec 31, 2023 | -18.68% |
| Sep 30, 2023 | -20.43% |
| Jun 30, 2023 | 0.74% |
| Mar 31, 2023 | 0.34% |
| Dec 31, 2022 | 19.91% |
| Sep 30, 2022 | -27.22% |
| Jun 30, 2022 | 43.55% |
| Mar 31, 2022 | -44.50% |
| Dec 31, 2021 | -47.80% |
| Sep 30, 2021 | 42.13% |